267 related articles for article (PubMed ID: 9042333)
21. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet actions of some coumarin compounds isolated from plant sources.
Teng CM; Li HL; Wu TS; Huang SC; Huang TF
Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611
[TBL] [Abstract][Full Text] [Related]
24. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists.
Hansen TN; Brockbank KG
Transfusion; 1997 Jul; 37(7):696-702. PubMed ID: 9225932
[TBL] [Abstract][Full Text] [Related]
25. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
26. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
[TBL] [Abstract][Full Text] [Related]
27. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
28. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
29. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
Pearce PH; Wright JM; Egan CM; Scrutton MC
Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
[TBL] [Abstract][Full Text] [Related]
30. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
31. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
32. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
[TBL] [Abstract][Full Text] [Related]
33. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients.
Polgár J; Eichler P; Greinacher A; Clemetson KJ
Blood; 1998 Jan; 91(2):549-54. PubMed ID: 9427708
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet activity of inositol hexaphosphate (IP6).
Vucenik I; Podczasy JJ; Shamsuddin AM
Anticancer Res; 1999; 19(5A):3689-93. PubMed ID: 10625941
[TBL] [Abstract][Full Text] [Related]
35. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
36. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
[TBL] [Abstract][Full Text] [Related]
37. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C-dependent and -independent mechanisms of dense granule exocytosis by human platelets.
Hashimoto Y; Togo M; Tsukamoto K; Horie Y; Watanabe T; Kurokawa K
Biochim Biophys Acta; 1994 May; 1222(1):56-62. PubMed ID: 8186265
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
[TBL] [Abstract][Full Text] [Related]
40. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]